RemeGen Co Ltd 9995.HK:Hong Kong Stock Exchange

*Data is delayed | Exchange | HKD
Last | 03/28/24 CTT
27.15quote price arrow up+1.50 (+5.85%)
Volume
1,144,427
52 week range
14.96 - 55.20
Loading...
  • Open25.65
  • Day High28.00
  • Day Low25.65
  • Prev Close25.65
  • 52 Week High55.20
  • 52 Week High Date04/14/23
  • 52 Week Low14.96
  • 52 Week Low Date02/05/24

Key Stats

  • Market Cap1,851.03M
  • Shares Out540.19M
  • 10 Day Average Volume1.94M
  • Dividend-
  • Dividend Yield-
  • Beta0.77
  • YTD % Change-27.5

KEY STATS

  • Open25.65
  • Day High28.00
  • Day Low25.65
  • Prev Close25.65
  • 52 Week High55.20
  • 52 Week High Date04/14/23
  • 52 Week Low14.96
  • 52 Week Low Date02/05/24
  • Market Cap1,851.03M
  • Shares Out540.19M
  • 10 Day Average Volume1.94M
  • Dividend-
  • Dividend Yield-
  • Beta0.77
  • YTD % Change-27.5

RATIOS/PROFITABILITY

  • EPS (TTM)-3.09
  • P/E (TTM)-8.80
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On RemeGen Co Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
RemeGen Co Ltd is a China-based company mainly engaged in the research, development and manufacture of innovative biopharmaceuticals. The Company is mainly engaged in the discovery, development and commercialization of therapeutic antibody drugs such as antibody drug conjugates (ADCs), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company's main products include tetacept (RC18), veldicitumab (RC48) and dual-target fusion protein (RC28). The...
Weidong Wang
Executive Chairman of the Board
Jianmin Fang
Chief Executive Officer, Chief Scientific Officer, General Manager, Executive Director
Daotian Fu
President
Shaojing Tong
Chief Financial Officer, Joint Company Secretary
Address
No.1 Rongchang Road, Yantai ETDZ
Yantai, SDG
264006
China